Loading clinical trials...
Loading clinical trials...
Previous studies indicate an association between severe psychiatric disorders, such as bipolar disorder, and increased risk of venous thromboembolism. However, to which extent this association is influenced by lithium treatment is currently unknown. In this prospective cohort study, the investigators aim to investigate the effect of bipolar disorder and lithium treatment on coagulation and the counterpart fibrinolysis.
The investigators will analyse differences in coagulation * using a case-control design where cases are bipolar patients not yet treated with lithium, and controls are healthy volunteers (Swedish ethical review authority Dnr 2023-05799-02, PI Kristoffer Månsson, KI). * using a prospective cohort design, following the patients over time.
Age
18 - 100 years
Sex
ALL
Healthy Volunteers
No
Karolinska Institutet
Stockholm, Sweden
Start Date
February 24, 2017
Primary Completion Date
April 1, 2025
Completion Date
April 1, 2025
Last Updated
February 19, 2025
68
ACTUAL participants
Lead Sponsor
Karolinska Institutet
NCT04480918
NCT07140913
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions